Oral Neoplasm
5
2
3
1
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
11 treatments under study, led by Standard Enditracheal Tube
Research Leaders
8 sponsors active, led by National Cancer Institute (NCI)
Related Conditions
Often studied with 20 related conditions
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 5 trials
100.0%
+13.4% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (5)
Widefield Fluorescence and Reflectance Imaging Systems and Oral Tissue Samples in Monitoring Participants at Risk for Developing Oral Cancer
Early Prediction of Oral Cancer by S100A7 Immunohistochemistry Signature-based Assessment
Arabic PRO Measures for Head and Neck Cancer Radiotherapy.
Comparison Between a Standard Tube and the Ultra-thin Tritube for Intubation of the Trachea and for Maintaining Access to the Trachea After Anaesthesia, in Patients With an Expected Difficult Direct Laryngoscopy
Cell-free Tumor DNA in Head and Neck Cancer Patients
Research Network
Common Treatments
- Standard Enditracheal Tube1
- Radiation1
- Fluorescence Spectroscopy1
- Standard Of Care Histopathology1
- Fluorescence Imaging1
Active Sponsors
- National Cancer Institute (NCI)1
- Department of Otorhinolaryngology, Head and Neck Surgery and Audiology1
- Michael Seltz Kristensen1
- Christian von Buchwald1
- M.D. Anderson Cancer Center1
Top Investigators
Department of Otorhinolaryngology, Head and Neck Surgery and Audiology
M.D. Anderson Cancer Center
Rigshospitalet, University Hospital of Copenhagen Denmark
Western University
Related Conditions
- Head And Neck Cancer2
- Nasopharyngeal Cancer2
- Oral Cancer2
- Oropharynx Cancer2
- Head And Neck Squamous Cell Carcinoma2